IDDI organized a webinar on Pros and Cons of Adaptive Designs.
Pros and Cons of Adaptive Designs
This webinar discussed adaptive designs for phase I, phase II and phase III clinical trials in oncology. The webinar took the form of a debate between two statisticians trying to meet the requirements of an oncologist. The pros and cons of various adaptive designs were discussed.
- Topics included:
- Continual reassessment methods for phase I trials
- Adaptive Bayesian designs for phase II trials
- Adaptive sample size increases and adaptive enrichment of phase III trials.
SPEAKERS:
